Genentech Acquires Seragon Pharmaceuticals for $1,725,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=29c67d46-a471-4d7b-9060-3a0f2795fbef
Date
7/2/2014
Company Name
Seragon Pharmaceuticals
Mailing Address
12780 El Camino Real San Diego, CA 92130 USA
Company Description
Seragon Pharmaceuticals is developing small-molecule drugs for the treatment of estrogen receptor dependent breast cancer.
Website
http://www.seragonpharm.com
Transaction Type
M&A
Transaction Amount
$1,725,000,000
Transaction Round
Proceeds Purposes
M&A Terms
Under the terms of the agreement, Genentech will make an upfront cash payment of $725 million, plus additional contingent payments of up to $1 billion based on achievement of certain predetermined milestones.